SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000950170-24-049044
Filing Date
2024-04-26
Accepted
2024-04-26 15:46:40
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A cue-defa14a-2024_naa_car.htm DEFA14A 48816
2 GRAPHIC img180382729_0.jpg GRAPHIC 102605
3 GRAPHIC img180382729_1.jpg GRAPHIC 71347
  Complete submission text file 0000950170-24-049044.txt   289707
Mailing Address 40 GUEST STREET BOSTON MA 02135
Business Address 40 GUEST STREET BOSTON MA 02135 617-949-2680
Cue Biopharma, Inc. (Filer) CIK: 0001645460 (see all company filings)

IRS No.: 473324577 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38327 | Film No.: 24883227
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)